Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 3
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02387229Phase 3Terminated

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

Role: collaborator

NCT03126214Phase 4Completed

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

Role: collaborator

NCT03221777Completed

Atrial Fibrillation Occurring Transiently With Stress (AFOTS)

Role: collaborator

NCT02392754Not ApplicableCompleted

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

Role: collaborator

All 4 trials loaded